Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Pfizer, Inc. (NYSE: PFE), Bristol-Myers Squibb Co. (NYSE: BMY), The Hershey Co. (NYSE: HSY), Kimberly Clark Corp. (NYSE: KMB) and Companhia de Saneamento Basico do Estado de São Paulo. (NYSE: SBS).
Get the most recent insight from Zacks Equity Research with the free Profit from the Pros newsletter: http://at.zacks.com/?id=4579
Here are highlights from Friday’s Analyst Blog:
Economic Data Mostly Turkeys
It is clear that we are in a very deep recession, and things are continuing to deteriorate. At this time, investors need to focus on the least economically sensitive equities with the strongest balance sheets. A high, well covered dividend yield is a plus.
Major drug companies like Pfizer, Inc. (NYSE: PFE) and Bristol-Myers Squibb Co. (NYSE: BMY) fit that description. Consumer Staples firms like The Hershey Company (NYSE: HSY) and Kimberly Clark Corporation (NYSE: KMB) also fit the bill.
SABESP Priced Absurdly Cheap
We are keeping our Buy recommendation on Companhia de Saneamento Basico do Estado de São Paulo, or SABESP (NYSE: SBS). The company posted reasonably positive results for the third quarter of 2008, even though its operating margins decreased.
The short-term outlook remains positive, due to the September 2008 tariff adjustment. Despite the recent depreciation in Brazilian real due to the global financial crisis, we believe that soon the Brazilian real will strengthen and that the company will benefit in the short term. Moreover, the regulatory framework for water and sewage in Brazil in 2006 helped the company in making all possible investments.
Want more from Zacks Equity Research? Subscribe to the free Profit from the Pros newsletter: http://at.zacks.com/?id=2649.
About Zacks Equity Research
Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.
Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.
Zacks "Profit from the Pros" e-mail newsletter provides highlights of the latest analysis from Zacks Equity Research. Subscribe to this free newsletter today: http://at.zacks.com/?id=2677
About Zacks
Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978 by Leonard Zacks. As a PhD in mathematics Len knew he could find patterns in stock market data that would lead to superior investment results. Amongst his many accomplishments was the formation of his proprietary stock picking system; the Zacks Rank, which continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros at http://at.zacks.com/?id=4580.
Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.
Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.
Contacts:
Mark Vickery
Web Content Editor
312-265-9380
Visit:
www.zacks.com
